Cyberonics backs noninvasive VNS firm
This article was originally published in Clinica
Executive Summary
Cyberonics, which pioneered the implantable vagus nerve stimulation (VNS) system, is investing up to €5.5 million ($7.1 million) in cerbomed, a privately-held German company that has developed a system that stimulates the vagus nerve noninvasively through the skin.